αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

NCT02151448 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
Malignant Peritoneal Mesothelioma
Peritoneal Carcinomatosis

Interventions

BIOLOGICAL: DC vaccine
DRUG: Celecoxib
DRUG: Interferon Alfa-2b
BIOLOGICAL: rintatolimod

Sponsor

David Bartlett

Collaborators

[object Object]